Tenet Healthcare (THC1) Stock Forecast & Price Target

2 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

THC1 Analyst Ratings

Strong Buy

15 Buy

1 Hold

0 Sell

Based on 16 analysts giving stock ratings to

Tenet

Healthcare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

THC1 Stock 12 Month Forecast

Average Price Target

€247.81

▲(8.69% Upside)

Based on 16 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is €247.81 with a high forecast of €274.35 and a low forecast of €213.38. The average price target represents a 8.69% change from the last price of €228.00.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"146":"€146","275":"€275","178.25":"€178.3","210.5":"€210.5","242.75":"€242.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":274.34913975,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€274.35</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":247.81420708000005,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€247.81</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":213.38266425,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€213.38</span>\n  </div></div>","useHTML":true}}],"tickPositions":[146,178.25,210.5,242.75,275],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,234,237.10377998076922,240.20755996153846,243.31133994230768,246.41511992307693,249.51889990384615,252.6226798846154,255.7264598653846,258.83023984615386,261.9340198269231,265.0377998076923,268.14157978846157,271.2453597692308,{"y":274.34913975,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,234,235.06263131384617,236.1252626276923,237.18789394153848,238.25052525538462,239.31315656923078,240.37578788307695,241.4384191969231,242.50105051076926,243.56368182461543,244.62631313846157,245.68894445230774,246.75157576615388,{"y":247.81420708000005,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,234,232.41405109615386,230.82810219230768,229.24215328846154,227.6562043846154,226.07025548076922,224.48430657692307,222.89835767307693,221.31240876923079,219.7264598653846,218.14051096153847,216.55456205769232,214.96861315384615,{"y":213.38266425,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":156,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":181,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":185,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":170,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":163,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":153,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":166,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":220,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":234,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 26,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€274.35

Average Price Target€247.81

Lowest Price Target€213.38

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

09/17/26

Leerink Partners Sticks to Their Buy Rating for Tenet Healthcare (THC)

Craig Hettenbach

Morgan Stanley

€238.64

Buy

4.67%

Upside

Reiterated

09/14/26

Buy Rating Reiterated on Tenet Healthcare as Durable Cost Cuts, ASC Strength and AI Efficiencies Support Unchanged $274 Price Target

Benjamin Rossi

J.P. Morgan

€274.35

Buy

20.33%

Upside

Reiterated

09/01/26

Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Phibro Animal Health (NASDAQ: PAHC) and Tenet Healthcare (NYSE: THC)

A.J. Rice

UBS

€268.25

Buy

17.65%

Upside

Reiterated

08/25/26

UBS Reaffirms Their Buy Rating on Tenet Healthcare (THC)

Ann Hynes

Mizuho Securities

€217.74→€252.58

Buy

10.78%

Upside

Reiterated

08/10/26

Tenet Healthcare price target raised to $290 from $250 at MizuhoTenet Healthcare price target raised to $290 from $250 at Mizuho

Kevin Fischbeck

Bank of America Securities

€252.58→€256.93

Buy

12.69%

Upside

Reiterated

08/10/26

Bank of America Securities Sticks to Their Buy Rating for Tenet Healthcare (THC)

Stephen Baxter

Wells Fargo

€201.19→€244.74

Buy

7.34%

Upside

Assigned

07/31/26

Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo

Scott Fidel

Goldman Sachs

€219.48→€265.64

Buy

16.51%

Upside

Assigned

07/29/26

Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs

David S Macdonald

Truist Financial

€235.16→€252.58

Buy

10.78%

Upside

Reiterated

07/28/26

Truist Financial Remains a Buy on Tenet Healthcare (THC)

Michael Ha

Robert W. Baird

€182.9→€243.87

Hold

6.96%

Upside

Reiterated

07/28/26

Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird

Jason Cassorla

Guggenheim

€210.77→€246.48

Buy

8.10%

Upside

Reiterated

07/27/26

Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim

Raj Kumar CFA

Stephens

€217.74→€248.22

Buy

8.87%

Upside

Reiterated

07/27/26

Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens

Ryan Langston

TD Cowen

€202.93→€229.06

Buy

0.46%

Upside

Assigned

07/27/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)

Ben Hendrix

RBC Capital

€205.54→€246.48

Buy

8.10%

Upside

Reiterated

07/26/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Andrew Mok CFA

Barclays

€209.03→€236.03

Buy

3.52%

Upside

Reiterated

07/24/26

Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Whit Mayo

Leerink Partners

―

Buy

―

Reiterated

09/17/26

Leerink Partners Sticks to Their Buy Rating for Tenet Healthcare (THC)

Craig Hettenbach

Morgan Stanley

€238.64

Buy

4.67%

Upside

Reiterated

09/14/26

Buy Rating Reiterated on Tenet Healthcare as Durable Cost Cuts, ASC Strength and AI Efficiencies Support Unchanged $274 Price Target

Benjamin Rossi

J.P. Morgan

€274.35

Buy

20.33%

Upside

Reiterated

09/01/26

Analysts Offer Insights on Healthcare Companies: Warby Parker (NYSE: WRBY), Phibro Animal Health (NASDAQ: PAHC) and Tenet Healthcare (NYSE: THC)

A.J. Rice

UBS

€268.25

Buy

17.65%

Upside

Reiterated

08/25/26

UBS Reaffirms Their Buy Rating on Tenet Healthcare (THC)

Ann Hynes

Mizuho Securities

€217.74→€252.58

Buy

10.78%

Upside

Reiterated

08/10/26

Tenet Healthcare price target raised to $290 from $250 at MizuhoTenet Healthcare price target raised to $290 from $250 at Mizuho

Kevin Fischbeck

Bank of America Securities

€252.58→€256.93

Buy

12.69%

Upside

Reiterated

08/10/26

Bank of America Securities Sticks to Their Buy Rating for Tenet Healthcare (THC)

Stephen Baxter

Wells Fargo

€201.19→€244.74

Buy

7.34%

Upside

Assigned

07/31/26

Tenet Healthcare price target raised to $281 from $231 at Wells FargoTenet Healthcare price target raised to $281 from $231 at Wells Fargo

Scott Fidel

Goldman Sachs

€219.48→€265.64

Buy

16.51%

Upside

Assigned

07/29/26

Tenet Healthcare price target raised to $305 from $252 at Goldman SachsTenet Healthcare price target raised to $305 from $252 at Goldman Sachs

David S Macdonald

Truist Financial

€235.16→€252.58

Buy

10.78%

Upside

Reiterated

07/28/26

Truist Financial Remains a Buy on Tenet Healthcare (THC)

Michael Ha

Robert W. Baird

€182.9→€243.87

Hold

6.96%

Upside

Reiterated

07/28/26

Tenet Healthcare price target raised to $280 from $210 at BairdTenet Healthcare price target raised to $280 from $210 at Baird

Jason Cassorla

Guggenheim

€210.77→€246.48

Buy

8.10%

Upside

Reiterated

07/27/26

Tenet Healthcare price target raised to $283 from $242 at GuggenheimTenet Healthcare price target raised to $283 from $242 at Guggenheim

Raj Kumar CFA

Stephens

€217.74→€248.22

Buy

8.87%

Upside

Reiterated

07/27/26

Tenet Healthcare price target raised to $285 from $250 at StephensTenet Healthcare price target raised to $285 from $250 at Stephens

Ryan Langston

TD Cowen

€202.93→€229.06

Buy

0.46%

Upside

Assigned

07/27/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC) and Dexcom (NASDAQ: DXCM)

Ben Hendrix

RBC Capital

€205.54→€246.48

Buy

8.10%

Upside

Reiterated

07/26/26

Analysts Offer Insights on Healthcare Companies: Tenet Healthcare (NYSE: THC), Legend Biotech (NASDAQ: LEGN) and Vertex Pharmaceuticals (NASDAQ: VRTX)

Andrew Mok CFA

Barclays

€209.03→€236.03

Buy

3.52%

Upside

Reiterated

07/24/26

Barclays Sticks to Its Buy Rating for Tenet Healthcare (THC)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

LGNDLigand Pharma

DNLIDenali Therapeutics

ACHVAchieve Life Sciences

PMNProMIS Neurosciences

CELCCelcuity

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Tenet Healthcare

3 Months

Andrew Mok CFABarclays

Success Rate

20/26 ratings generated profit

Average Return

+10.16%

Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +10.16% per trade.

1 Year

David S MacdonaldTruist Financial

Success Rate

26/28 ratings generated profit

Average Return

+37.23%

Copying David S Macdonald's trades and holding each position for 1 Year would result in 92.86% of your transactions generating a profit, with an average return of +37.23% per trade.

2 Years

Jason CassorlaGuggenheim

Success Rate

17/17 ratings generated profit

Average Return

+89.96%

Copying Jason Cassorla's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +89.96% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

THC1 Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, THC1 has received 26 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. THC1 average Analyst price target in the past 3 months is 247.81.

Each month's total comprises the sum of three months' worth of ratings.

THC1 Financial Forecast

THC1 Earnings Forecast

Next quarter’s earnings estimate for THC1 is €4.01 with a range of €3.46 to €4.33. The previous quarter’s EPS was €5.25. THC1 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Sales Forecast

Next quarter’s sales forecast for THC1 is €4.71B with a range of €4.65B to €4.78B. The previous quarter’s sales results were €4.83B. THC1 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year THC1 has Performed in-line its overall industry.

THC1 Stock Forecast FAQ

What is DE:THC1’s average 12-month price target, according to analysts?

Based on analyst ratings, Tenet Healthcare’s 12-month average price target is 247.81.

What is DE:THC1’s upside potential, based on the analysts’ average price target?

Tenet Healthcare has 8.69% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Tenet Healthcare a Buy, Sell or Hold?

Tenet Healthcare has a consensus rating of Strong Buy, which is based on 15 buy ratings, 1 hold ratings and 0 sell ratings.

What is Tenet Healthcare’s share price target?

The average share price target for Tenet Healthcare is 247.81. This is based on 16 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €274.35 ,and the lowest forecast is €213.38. The average share price target represents 8.69% Increase from the current price of €228.

What do analysts say about Tenet Healthcare?

Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 16 Wall Streets Analysts.

How can I buy shares of Tenet Healthcare?

To buy shares of DE:THC1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Tenet Healthcare (THC1) Stock Forecast & Price Target

THC1 Analyst Ratings

THC1 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Tenet Healthcare

THC1 Analyst Recommendation Trends

THC1 Financial Forecast

THC1 Earnings Forecast

THC1 Sales Forecast

THC1 Stock Forecast FAQ

Detailed List of Analyst Forecasts